Javascript must be enabled to continue!
Unveiling the hidden link: fungi and HPV in cervical lesions
View through CrossRef
BackgroundCervical cancer, primarily driven by high-risk human papillomavirus (HR-HPV) infection, ranks as the second most common cancer globally. Understanding combined infections’ role, including Cervical fungi, is crucial in cervical carcinogenesis. This study aims to explore the potential correlation between HR-HPV, cervical fungi, and cervical cancer, while adjusting for various factors.MethodsThe study population comprised patients undergoing colposcopy and conization due to abnormal cervical screening results. Clinical data including age, gravidity, HPV (human papillomavirus) genotypes, cervical pathology, and p16/Ki67 expression were extracted. Cervical TCT (ThinPrep Pap Test) and HPV testing are utilized for screening cervical lesions, with fungal presence suggested by TCT results. 5,528 participants were included in this study. Statistical analyses investigated associations between HPV/fungi co-infection and cervical lesions, employing multinomial logistic regression and interaction analysis.ResultsCo-infection with fungi and HPV may decrease the risk of cervical lesions compared to HPV infection alone. In the co-infection group, compared with HPV infection alone, the risk of low-grade squamous intraepithelial lesions (LSIL) was reduced by 27% (OR = 0.73, 95% CI: 0.59–0.90), the risk of high-grade squamous intraepithelial lesions (HSIL) was reduced by 35% (OR = 0.65, 95% CI: 0.51–0.82), and the risk of cervical cancer was reduced by 43% (OR = 0.57, 95% CI: 0.35–0.92). The interaction analysis revealed a negative interaction between fungal and HPV infections in the development of cervical cancer (RERI = −6.25, AP = −0.79, SI = 0.52), HSIL (RERI = −19.15, AP = −0.37, SI = 0.72) and LSIL (RERI = −1.87, AP = −0.33, SI = 0.71), suggesting a sub-additive effect, where the combined effect of the two infections was less than the sum of their individual effects. This indicates that fungal infection may attenuate the promoting effect of HPV on cervical lesions. In exploring the potential mechanism, we found that the co-infection group had significantly lower p16 positivity (54.6%) compared to the HPV-only group (60.2%) (p = 0.004), while there was no statistically significant difference in Ki67 positivity.ConclusionThis study unveils the intricate relationship between cervical fungi and HPV in cervical lesions. Co-infection with fungi and HPV against cervical lesions compared to HPV infection alone, indicating a novel clinical interaction. Lower p16 positivity in co-infection hints at a protective mechanism, urging further exploration.
Title: Unveiling the hidden link: fungi and HPV in cervical lesions
Description:
BackgroundCervical cancer, primarily driven by high-risk human papillomavirus (HR-HPV) infection, ranks as the second most common cancer globally.
Understanding combined infections’ role, including Cervical fungi, is crucial in cervical carcinogenesis.
This study aims to explore the potential correlation between HR-HPV, cervical fungi, and cervical cancer, while adjusting for various factors.
MethodsThe study population comprised patients undergoing colposcopy and conization due to abnormal cervical screening results.
Clinical data including age, gravidity, HPV (human papillomavirus) genotypes, cervical pathology, and p16/Ki67 expression were extracted.
Cervical TCT (ThinPrep Pap Test) and HPV testing are utilized for screening cervical lesions, with fungal presence suggested by TCT results.
5,528 participants were included in this study.
Statistical analyses investigated associations between HPV/fungi co-infection and cervical lesions, employing multinomial logistic regression and interaction analysis.
ResultsCo-infection with fungi and HPV may decrease the risk of cervical lesions compared to HPV infection alone.
In the co-infection group, compared with HPV infection alone, the risk of low-grade squamous intraepithelial lesions (LSIL) was reduced by 27% (OR = 0.
73, 95% CI: 0.
59–0.
90), the risk of high-grade squamous intraepithelial lesions (HSIL) was reduced by 35% (OR = 0.
65, 95% CI: 0.
51–0.
82), and the risk of cervical cancer was reduced by 43% (OR = 0.
57, 95% CI: 0.
35–0.
92).
The interaction analysis revealed a negative interaction between fungal and HPV infections in the development of cervical cancer (RERI = −6.
25, AP = −0.
79, SI = 0.
52), HSIL (RERI = −19.
15, AP = −0.
37, SI = 0.
72) and LSIL (RERI = −1.
87, AP = −0.
33, SI = 0.
71), suggesting a sub-additive effect, where the combined effect of the two infections was less than the sum of their individual effects.
This indicates that fungal infection may attenuate the promoting effect of HPV on cervical lesions.
In exploring the potential mechanism, we found that the co-infection group had significantly lower p16 positivity (54.
6%) compared to the HPV-only group (60.
2%) (p = 0.
004), while there was no statistically significant difference in Ki67 positivity.
ConclusionThis study unveils the intricate relationship between cervical fungi and HPV in cervical lesions.
Co-infection with fungi and HPV against cervical lesions compared to HPV infection alone, indicating a novel clinical interaction.
Lower p16 positivity in co-infection hints at a protective mechanism, urging further exploration.
Related Results
Evaluation of female university students’ knowledge, attitudes, and practices toward human papillomavirus infection and vaccination. Multicenter cross-sectional study
Evaluation of female university students’ knowledge, attitudes, and practices toward human papillomavirus infection and vaccination. Multicenter cross-sectional study
Abstract
Introduction
Having good knowledge and a favorable attitude toward human papillomavirus (HPV) and HPV vaccinations is the cornerstone for i...
Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
BackgroundCervical cancer is the 4th most common cancer in women globally. Determining the prevalence of the high-risk human papillomavirus (HR-HPV) and low-risk (LR-HPV) genotypes...
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
SummaryResearch in contextEvidence before this studyWe first searched PubMed for articles published until November 2023 with the keywords “(“HPV”) AND (“Vaccine” or “Vaccination”) ...
Abstract PR01: HPV structure and functional alterations impact prognosis in HPV (+) oropharyngeal squamous cell carcinoma
Abstract PR01: HPV structure and functional alterations impact prognosis in HPV (+) oropharyngeal squamous cell carcinoma
Abstract
Background: Over the last two decades, there has been a sharp increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) linked to human pap...
Prevalence and Genotype Spectrum of HPV Infection among Women in Xuhui District, Shanghai: Insights for Regional Cervical Cancer Screening Strategies
Prevalence and Genotype Spectrum of HPV Infection among Women in Xuhui District, Shanghai: Insights for Regional Cervical Cancer Screening Strategies
Abstract
Objective: Numerous epidemiological analyses suggest that high-risk HPV infections are a major cause of cervical cancer, with variations in HPV distribution among ...
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
AbstractThe World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention strategy to control the burden of cervical...
Monitoring Circulating Cell-Free HPV DNA in Metastatic and Recurrent Cervical Cancer: Clinical Importance and Implications for Treatment – A Pilot Study
Monitoring Circulating Cell-Free HPV DNA in Metastatic and Recurrent Cervical Cancer: Clinical Importance and Implications for Treatment – A Pilot Study
PURPOSE: Monitoring circulating human papillomavirus (HPV) cell-free DNA (cfDNA) is a minimally invasive approach for surveillance in HPV-associated cancers, particularly cervical ...
Monitoring Circulating Cell-free HPV DNA in Metastatic and Recurrent Cervical Cancer: Clinical Importance and Implications for Treatment - A Pilot Study
Monitoring Circulating Cell-free HPV DNA in Metastatic and Recurrent Cervical Cancer: Clinical Importance and Implications for Treatment - A Pilot Study
Abstract
Purpose
Monitoring of circulating human papillomavirus (HPV) cell-free DNA (cfDNA) is a minimally invasive approach for surveillance in HPV-associated cancers, particularl...


